Dysport ® achieved statistically significant topline Phase III results, meeting primary endpoints in both episodic (E-BEOND) and chronic (C-BEOND) migraine Dysport is the first botulinum toxin in ...
Dysport® achieved statistically significant topline Phase III results, meeting primary endpoints in both episodic (E-BEOND) and chronic (C-BEOND) migraine Dysport is the first botulinum toxin in ...
WASHINGTON, July 1 (Reuters) - Commonwealth Fusion Systems, a U.S. company attempting to generate electricity by replicating the process that fuels the stars, said on Wednesday it is joining a UK ...
Wearable devices, such as smartwatches and activity trackers, are commonly used by patients in their everyday lives to manage their health and well-being. These devices collect and analyze long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results